Medical News Today -- The coagulation system is implicated in cancer proliferation, angiogenesis, host immunologic defense, and metastasis. Patients with cancer are more likely to develop thromboembolism. In the journal Cancer, Dr. Kevin Choe and colleagues report on a cohort of patients receiving radiotherapy (XRT) for prostate cancer (CaP) of which 37% also received some form of anticoagulation.
